COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?
Por:
Pallarés Carratalá V, Górriz-Zambrano C, Morillas Ariño C, Llisterri Caro JL and Gorriz JL
Publicada:
1 ago 2020
Ahead of Print:
11 may 2020
Resumen:
The SARS-CoV-2 pandemic is a global health emergency and we need to know more about it.
Patients with cardiovascular risk and previous kidney risk have been identified as especially vulnerable for greater morbidity and mortality when they suffer from COVID-19. A considerable proportion of patients can develop a vascular lesion in the context of the disease that entails a greater lethality. Cardiovascular and renal complications represent a problem and, probably in the near future, may pose a threat to patients who have survived COVID-19.
As physicians, we cannot forget that during an epidemic like this, other chronic diseases are present, and patients continue to require care. We are obliged to monitor even more intensely their treatments and control degree. Furthermore, we must not forget that urgent situations continue to arise in this pandemic situation and require prompt attention. In this current situation, it is very likely that many patients, out of fear, have not sought medical attention.
The situation during the epidemic and the uncertainty of the post-COVID-19 period, requires intensification in the control and monitoring of cardiovascular and kidney disease in our patients. Primary care constitutes a key level of care for the care of the population with cardiovascular disease. Likewise, and in the face of this new health scenario, we need to promote the prevention and control measures that emanate from the studies currently underway. Now, more than ever, we need research, crucial to improve the cardiovascular and renal prognosis of our patients. (c) 2020 Sociedad Espanola de Medicos de Atencion Primaria (SEMERGEN). Published by Elsevier Espana, S.L.U. All rights reserved.
Filiaciones:
Pallarés Carratalá V:
Medicina Familiar y Comunitaria, Unidad de Vigilancia de la Salud, Unión de Mutuas, Castellón, España
Departamento de Medicina, Facultad de Ciencias de la Salud, Universitat JaumeI, Castellón, España
Górriz-Zambrano C:
Medicina Familiar y Comunitaria, CAP Sant Pere, ABS Reus1, Reus, Tarragona, España
:
Servicio de Endocrinología, Hospital Universitario Dr. Peset, Valencia, España
Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España
:
Medicina Familiar y Comunitaria, Fundación de Investigación SEMERGEN (Madrid), Clínica Vallada, Valencia, España
Gorriz JL:
Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España
Servicio de Nefrología, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia, España
Bronze, Green Published
|